Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Pearmain

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Breathe (Sheffield, England)|September 18, 2023
Add-on therapy for pulmonary fibrosis, a forthcoming era with implications for practice: the BI 101550 and RELIEF trialsLurdes Planas-Cerezales, Laura Fabbri, Laurence Pearmain
Clinical Medicine (London, England)|January 17, 2020
Lessons of the month 1: Salbutamol induced lactic acidosis: clinically recognised but often forgottenLaurence Pearmain, Ravi Gupta, Rowland J Bright-Thomas
BMJ Case Reports|July 29, 2017
Persistent air leak after pulmonary transplantationLaurence Pearmain, Piotr Krysiak, John Blaikley, et al.
Thorax|May 27, 2025
Epithelial damage and ageing: the perfect stormRichard J Hewitt, Laurence Pearmain, Elisavet Lyka, et al.
Biomedicines|May 27, 2023
Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease ModellingAdam Mitchell, Chaowen Yu, Xiangjun Zhao, et al.
Journal of Breath Research|August 24, 2023
Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-<i>β</i>1Conal Hayton, Waqar Ahmed, Peter Cunningham, et al.
BMJ Open Respiratory Research|June 14, 2022
Large scale clinical trials: lessons from the COVID-19 pandemicAlex R Horsley, Laurence Pearmain, Sean Knight, et al.
Cell Reports|November 15, 2023
PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosisElliot Jokl, Aoibheann F Mullan, Kara Simpson, et al.
EMBO Molecular Medicine|November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosisVarinder S Athwal, James Pritchett, Jessica Llewellyn, et al.
Med (New York, N.Y.)|April 6, 2021
Alterations in T and B cell function persist in convalescent COVID-19 patientsHalima A Shuwa, Tovah N Shaw, Sean B Knight, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Breathe (Sheffield, England)|September 18, 2023
Add-on therapy for pulmonary fibrosis, a forthcoming era with implications for practice: the BI 101550 and RELIEF trialsLurdes Planas-Cerezales, Laura Fabbri, Laurence Pearmain
Clinical Medicine (London, England)|January 17, 2020
Lessons of the month 1: Salbutamol induced lactic acidosis: clinically recognised but often forgottenLaurence Pearmain, Ravi Gupta, Rowland J Bright-Thomas
BMJ Case Reports|July 29, 2017
Persistent air leak after pulmonary transplantationLaurence Pearmain, Piotr Krysiak, John Blaikley, et al.
Thorax|May 27, 2025
Epithelial damage and ageing: the perfect stormRichard J Hewitt, Laurence Pearmain, Elisavet Lyka, et al.
Biomedicines|May 27, 2023
Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease ModellingAdam Mitchell, Chaowen Yu, Xiangjun Zhao, et al.
Journal of Breath Research|August 24, 2023
Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-<i>β</i>1Conal Hayton, Waqar Ahmed, Peter Cunningham, et al.
BMJ Open Respiratory Research|June 14, 2022
Large scale clinical trials: lessons from the COVID-19 pandemicAlex R Horsley, Laurence Pearmain, Sean Knight, et al.
Cell Reports|November 15, 2023
PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosisElliot Jokl, Aoibheann F Mullan, Kara Simpson, et al.
EMBO Molecular Medicine|November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosisVarinder S Athwal, James Pritchett, Jessica Llewellyn, et al.
Med (New York, N.Y.)|April 6, 2021
Alterations in T and B cell function persist in convalescent COVID-19 patientsHalima A Shuwa, Tovah N Shaw, Sean B Knight, et al.
Pageof 2